<scp>SARS‐CoV</scp>‐2‐reactive antibody detection after <scp>SARS‐CoV</scp>‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy GroupJosé Luís Piñana, Anna Sureda, Lucía López‐Corral et al.|American Journal of Hematology|2021Cited by 64
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luís Piñana, David Navarro, Lucía López‐Corral et al.|Journal of Hematology & Oncology|2022Cited by 39
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimensTamara Castaño-Bonilla, Pau Montesinos, Alberto María Torre Cantalapiedra et al.|Scientific Reports|2021Cited by 25
Quizartinib for Newly Diagnosed <i>FLT3</i> -Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI StudyPau Montesinos, Jorge Labrador, Rebeca Rodríguez‐Veiga et al.|Journal of Clinical Oncology|2025Cited by 13
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA GroupTamara Castaño-Bonilla, Pau Montesinos, Eva Barragán et al.|Disease Markers|2022Cited by 2